标题
An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
作者
关键词
-
出版物
Neurotherapeutics
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-01-15
DOI
10.1007/s13311-022-01183-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Using bumetanide to treat autism appears promising but further clinical trials are needed to confirm this approach
- (2021) Yehezkel Ben‐Ari et al. ACTA PAEDIATRICA
- Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
- (2021) Hana Štorkánová et al. Scientific Reports
- Targeting the RHOA pathway improves learning and memory in adult Kctd13 and 16p11.2 deletion mouse models
- (2021) Sandra Martin Lorenzo et al. Molecular Autism
- Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease
- (2021) Felipe Patricio et al. Frontiers in Pharmacology
- Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis
- (2021) Yi Huang et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabinoid treatment for autism: a proof-of-concept randomized trial
- (2021) Adi Aran et al. Molecular Autism
- Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial
- (2021) Elizabeth M. Berry-Kravis et al. NATURE MEDICINE
- Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial
- (2021) Xue-Jun Kong et al. Nutrients
- Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database
- (2021) Aliya G. Feroe et al. JAMA Pediatrics
- Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder
- (2021) Linmarie Sikich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2018
- (2021) Matthew J. Maenner et al. MMWR Surveillance Summaries
- Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder
- (2020) Ashura Williams Buckley et al. NEUROLOGY
- The Sigma-1 Receptor at the Crossroad of Proteostasis, Neurodegeneration, and Autophagy
- (2020) Maximilian G. Christ et al. TRENDS IN NEUROSCIENCES
- Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up
- (2020) Sylvie Bernaerts et al. Molecular Autism
- Sulforaphane as an anticancer molecule: mechanisms of action, synergistic effects, enhancement of drug safety, and delivery systems
- (2020) Mohammad M. Kamal et al. ARCHIVES OF PHARMACAL RESEARCH
- Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome
- (2020) Angela John Thurman et al. Journal of Neurodevelopmental Disorders
- Effects of sulforaphane on brain mitochondria: mechanistic view and future directions
- (2020) Fernanda Rafaela Jardim et al. Journal of Zhejiang University-SCIENCE B
- A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome
- (2020) Elizabeth Berry-Kravis et al. PEDIATRIC NEUROLOGY
- Rationale, design, and methods of the autism centers of excellence (ACE) network study of oxytocin in autism to improve reciprocal social behaviors (SOARS-B)
- (2020) Marina Spanos et al. Contemporary Clinical Trials
- Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase Two, Superiority Trial
- (2020) Jan J. Sprengers et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments
- (2020) Richard E. Frye Seminars in Pediatric Neurology
- IGF-1 treatment causes unique transcriptional response in neurons from individuals with idiopathic autism
- (2020) Sara B. Linker et al. Molecular Autism
- Practitioner Review: Pharmacological treatment of attention‐deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta‐analysis
- (2020) Rebecca Rodrigues et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Bumetanide for autism: Open‐label trial in six children
- (2020) Elisabeth Fernell et al. ACTA PAEDIATRICA
- Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome
- (2019) Daniel G. Glaze et al. NEUROLOGY
- Cognitive and behavioral improvement in adults with fragile X syndrome treated with metformin‐two cases
- (2019) Dragana Protic et al. Molecular Genetics & Genomic Medicine
- Systematic Review of Sleep Disturbances and Circadian Sleep Desynchronization in Autism Spectrum Disorder: Toward an Integrative Model of a Self-Reinforcing Loop
- (2019) Claudia Carmassi et al. Frontiers in Psychiatry
- A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome
- (2019) Helen Heussler et al. Journal of Neurodevelopmental Disorders
- Metformin treatment in young children with fragile X syndrome
- (2019) Hazel Maridith B. Biag et al. Molecular Genetics & Genomic Medicine
- Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders
- (2019) Md. Sahab Uddin et al. SCIENCE OF THE TOTAL ENVIRONMENT
- A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder
- (2019) Laura A. Potter et al. Frontiers in Psychiatry
- ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome
- (2019) Walter E. Kaufmann et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial
- (2018) Hidenori Yamasue et al. MOLECULAR PSYCHIATRY
- Inferential language use by school-aged boys with fragile X syndrome: Effects of a parent-implemented spoken language intervention
- (2018) Sarah Nelson et al. JOURNAL OF COMMUNICATION DISORDERS
- Bumetanide for autism: more eye contact, less amygdala activation
- (2018) Nouchine Hadjikhani et al. Scientific Reports
- Bumetanide for Autism Spectrum Disorder in Children: A Review of Randomized Controlled Trials
- (2018) B. Jordan James et al. ANNALS OF PHARMACOTHERAPY
- Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders
- (2018) Ilse Gantois et al. Annual Review of Medicine
- A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder
- (2018) Hajar Mazahery et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Arbaclofen in fragile X syndrome: results of phase 3 trials
- (2017) Elizabeth Berry-Kravis et al. Journal of Neurodevelopmental Disorders
- Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder
- (2017) Paul Gringras et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice
- (2017) Laura J Stoppel et al. NEUROPSYCHOPHARMACOLOGY
- The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors
- (2017) T. Bakas et al. PHARMACOLOGICAL RESEARCH
- Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism
- (2017) Karen J. Parker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
- (2017) E Lemonnier et al. Translational Psychiatry
- Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D)
- (2017) Mark E. Gurney et al. Scientific Reports
- NEW EXPLORATORY ALZHEIMER’S DRUG ANAVEX 2-73: DOSE DEPENDENT CLINICAL COGNITIVE IMPROVEMENT OBSERVED IN MINI MENTAL STATE EXAMINATION (MMSE) AND OTHER COGNITIVE MARKERS IN A PHASE 2A STUDY IN MILD-TO-MODERATE ALZHEIMER’S PATIENTS
- (2016) Stephen Macfarlane et al. Alzheimers & Dementia
- Sulforaphane Treatment of Young Men with Autism Spectrum Disorder
- (2016) Kanwaljit Singh et al. CNS & Neurological Disorders-Drug Targets
- A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome
- (2016) Laura Greiss Hess et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Effects of Methylphenidate on Sleep Functioning in Children with Attention-Deficit/Hyperactivity Disorder
- (2016) Stephen P. Becker et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model
- (2016) R E Monyak et al. MOLECULAR PSYCHIATRY
- Intranasal Oxytocin Enhances Connectivity in the Neural Circuitry Supporting Social Motivation and Social Perception in Children with Autism
- (2016) Ilanit Gordon et al. Scientific Reports
- Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome
- (2015) Mei Qin et al. BEHAVIOURAL BRAIN RESEARCH
- A Pilot Study on the Combination of Applied Behavior Analysis and Bumetanide Treatment for Children with Autism
- (2015) Lin Du et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial
- (2015) C J Yatawara et al. MOLECULAR PSYCHIATRY
- NNZ-2566, a Novel Analog of (1–3) IGF-1, as a Potential Therapeutic Agent for Fragile X Syndrome
- (2015) Robert M. J. Deacon et al. NEUROMOLECULAR MEDICINE
- GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism
- (2015) J L Silverman et al. NEUROPSYCHOPHARMACOLOGY
- Early Intervention for Children With Autism Spectrum Disorder Under 3 Years of Age: Recommendations for Practice and Research
- (2015) L. Zwaigenbaum et al. PEDIATRICS
- Update on the implication of potassium channels in autism: K+ channelautism spectrum disorder
- (2015) Luca Guglielmi Frontiers in Cellular Neuroscience
- Cytotoxic and Antitumor Activity of Sulforaphane: The Role of Reactive Oxygen Species
- (2015) Piero Sestili et al. Biomed Research International
- Intranasal oxytocin in the treatment of autism spectrum disorders: A review of literature and early safety and efficacy data in youth
- (2014) Evdokia Anagnostou et al. BRAIN RESEARCH
- The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial
- (2014) Adam J. Guastella et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Sulforaphane treatment of autism spectrum disorder (ASD)
- (2014) K. Singh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resequencing and association analysis ofOXTRwith autism spectrum disorder in a Japanese population
- (2014) Jun Egawa et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Alpha-2 Agonists for Attention-Deficit/Hyperactivity Disorder in Youth: A Systematic Review and Meta-Analysis of Monotherapy and Add-On Trials to Stimulant Therapy
- (2013) Tomoya Hirota et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients
- (2013) Aleksandr Shcheglovitov et al. NATURE
- Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome
- (2013) Emily K. Osterweil et al. NEURON
- Comorbidity Clusters in Autism Spectrum Disorders: An Electronic Health Record Time-Series Analysis
- (2013) Finale Doshi-Velez et al. PEDIATRICS
- Psychotropic Medication Use and Polypharmacy in Children With Autism Spectrum Disorders
- (2013) D. Spencer et al. PEDIATRICS
- Oxytocin enhances brain function in children with autism
- (2013) I. Gordon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decreased tryptophan metabolism in patients with autism spectrum disorders
- (2013) Luigi Boccuto et al. Molecular Autism
- Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay
- (2013) Ozlem Bozdagi et al. Molecular Autism
- A Randomized Controlled Pilot Trial of Oral N-Acetylcysteine in Children with Autism
- (2012) Antonio Y. Hardan et al. BIOLOGICAL PSYCHIATRY
- Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells
- (2012) NILUFAR ESFAHANIAN et al. Molecular Medicine Reports
- Brain-derived neurotrophic factor increases the motility of a particular N-methyl-d-aspartate /GABA-responsive subset of neural progenitor cells
- (2012) L.C. Jansson et al. NEUROSCIENCE
- Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum Disorders
- (2012) Daniel L. Coury et al. PEDIATRICS
- Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen
- (2012) C. Henderson et al. Science Translational Medicine
- Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial
- (2012) E. M. Berry-Kravis et al. Science Translational Medicine
- Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial
- (2012) Evdokia Anagnostou et al. Molecular Autism
- A randomised controlled trial of bumetanide in the treatment of autism in children
- (2012) E Lemonnier et al. Translational Psychiatry
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Prosocial effects of oxytocin and clinical evidence for its therapeutic potential
- (2011) Nadine Striepens et al. FRONTIERS IN NEUROENDOCRINOLOGY
- The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects
- (2010) Eric Lemonnier et al. ACTA PAEDIATRICA
- Frequency of symptoms of attention deficit and hyperactivity disorder in autistic children
- (2010) Milena Pereira Pondé et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Autism Spectrum Disorder and Co-occurring Developmental, Psychiatric, and Medical Conditions Among Children in Multiple Populations of the United States
- (2010) Susan E. Levy et al. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
- The role of fragile X mental retardation protein in major mental disorders
- (2010) S. Hossein Fatemi et al. NEUROPHARMACOLOGY
- Fragile X mental retardation protein levels are decreased in major psychiatric disorders
- (2010) S. Hossein Fatemi et al. SCHIZOPHRENIA RESEARCH
- Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders
- (2009) Adam J. Guastella et al. BIOLOGICAL PSYCHIATRY
- Attention Deficit/Hyperactivity Disorder in Children and Adolescents With Autism Spectrum Disorder
- (2009) Judith Sinzig et al. Journal of Attention Disorders
- Psychiatric Disorders in Children With Autism Spectrum Disorders: Prevalence, Comorbidity, and Associated Factors in a Population-Derived Sample
- (2009) Emily Simonoff et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver Model
- (2009) G. Dawson et al. PEDIATRICS
- Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
- (2009) R. Owen et al. PEDIATRICS
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
- (2009) Daniela Tropea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum Disorders
- (2008) D. S. Mandell et al. PEDIATRICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now